Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses

Nature Biotechnology

Volumn 17, Issue 7, 1999, Pages 660-665

  Kieber Emmons, Thomas ^a   Luo, Ping ^a   Qiu, Jianping ^a   Chang, Tylis Y ^a   Blaszczyk Thurin, Magdalena ^b   Steplewski, Zenon ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cancer; Carbohydrate; Lewis Y; Meth A; Mimic; Mimotype; Vaccine

Indexed keywords

CANCER VACCINE; CARBOHYDRATE ANTIGEN; TUMOR ANTIGEN;

ANTIBODY RESPONSE; ARTICLE; CANCER CELL DESTRUCTION; CANCER IMMUNIZATION; CANCER SURVIVAL; CONTROLLED STUDY; EPITOPE MAPPING; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; MOLECULAR MIMICRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CANCER VACCINES; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; LEWIS BLOOD-GROUP SYSTEM; MICE; MICE, INBRED BALB C; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PEPTIDES; SARCOMA, EXPERIMENTAL; TUMOR CELLS, CULTURED; VACCINATION;

ANIMALIA; MURINAE;

EID: 0032978987     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/10870     Document Type: Article

References (46)

1. Hakomori, S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer Rres. 52, 257-331 (1989).
2. Livingston, P.O. & Ragupathi, G. Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans. Cancer Immunol. Immunother. 45, 10-19(1997).
3. Mond, J.J., Lees, A. & Snapper, C.M. T cell-independent antigens type 2. [Review]. Annu. Rev. Immunol. 13, 655-692 (1995).
4. Livingston, P.O., Zhang, S. & Lloyd, K.O. Carbohydrate vaccines that induce antibodies against cancer. 1.Rationale. Cancer Immunol., Immunother. 45, 1-9(1997).
5. Chapman, P.B. Anti-idiotypic monoclonal antibody cancer vaccines. Semin. Cancer Biol. 6, 367-374 (1995).
6. Hoess, R., Brinkmann, U., Handel, T. & Pastan, I. Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3. Gene 128, 43-49 (1993).
7. Luo, R et al. Antigenic and immunological mimicry of peptide mimotopes of adenocarcinoma associated carbohydrate antigens. Mol. Immunol. 13, 865-879 (1998).
8. Qiu, J., Luo, P., Wasmund, K., Steplewski, Z. & Kieber-Emmons, T. Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines. Hybridoma 18, 103-112 (1999).
9. Taki, T., Ishikawa, D., Hamasaki, H. & Handa, S. Preparation of peptides which mimic glycosphingolipids by using phage peptide library and their modulation on beta-galactosidase activity. FEBS Lett. 418, 219-223 (1997).
10. Oldenburg, K.R., Loganathan, D., Goldstein, I.J., Schultz, P.G. & Gallop, M.A. Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc. Natl. Acad. Sci. USA 89, 5393-5397 (1992).
11. Scott, J.K., Loganathan, D., Easley, R.B., Gong, X. & Goldstein, I.J. A family of concanavalin A-binding peptides from a hexapeptide epitope library. Proc. Natl. Acad. Sci. USA 89, 5398-5402 (1992).
12. Murai, H. et al. Amino acid sequence of protein alpha-amylase inhibitor from Streptomyces griseosporeus YM-25. J. Biochem. 97, 1129-1133 (1985).
13. Westerink, M.A.J., Giardina, P.C., Apicella, M.A & Kieber-Emmons, T. Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc. Natl. Acad. Sci. USA 92, 4021 -4025 (1995).
14. Imberty, A. et al. Computer simulation of histo-blood group oligosaccharides: energy maps of all constituting disaccharides and potential energy surfaces of 14 ABH and Lewis carbohydrate antigens. Glycoconjugate J. 12, 331-349 (1995).
15. Agadjanyan, M. et al. Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus. Nat. Biotechnol. 15, 547-551 (1997).
16. Fehr, T. et al. Role of repetitive antigen patterns for induction of antibodies against antibodies. J. Exp. Med. 185, 1785-1792 (1997).
17. Zhang, S. et al. Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen. Cancer Res. 55, 3364-3368 (1995).
18. Kudryashov, V. et al. Immunogenicity of synthetic conjugates of Lewis(y) oligosaccharide with proteins in mice: towards the design of anticancer vaccines. Cancer Immunol. Immunother. 45, 281-286 (1998).
19. Steplewski, Z. et al. Tumor cell lysis and tumor growth inhibition by the isotype variants of MAb BR55-2 directed against Y oligosaccharide. In Vivo 5, 79-83 (1991).
20. Noguchi, Y, Richards, E.C., Chen, Y.T. & Old, L.J. Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proc. Natl. Acad. Sci.. USA 92, 2219-2223(1995).
21. Jiao, Y. & Fujimoto, S. Sequential T cell response involved in tumor rejection of sarcoma, Meth A, in syngeneic mice. Jpn. J. Cancer Res. 89, 657-665 (1998).
22. Tsuyuoka, K. et al. Characterization of a T-cell line specific to an anti-Id antibody related to the carbohydrate antigen, sialyl ssea-1, and the immunodominant T-cell antigenic site of the antibody. J. Immunol. 157, 661-669 (1996).
23. Helling, F. et al. GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21. Cancer Res. 55, 2783-2788 (1995).
24. Kitamura, K. et al. Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine. Proc. Natl. Acad. Sci. USA 92, 2805-2809 (1995).
25. Longenecker, B.M., Reddish, M., Koganty, R. & MacLean, G.D. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis. Adv. Exp. Med. Biol. 353, 105-124 (1994).
26. Jones, R.C. et al. Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: an immunologic survival model. Ann. Surg. Oncol. 3, 437-445 (1996).
27. Pantel, K. et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 347, 649-653 (1996).
28. Houghton, A.N. & Lloyd, K.O. Stuck in the MUC on the long and winding road. Nat. Med. 4, 270-271 (1998).
29. Ravindranath, M.H. et al. Ratio of IgG:IgM antibodies to sialyl Lewis(x) and GM3 correlates with tumor growth after immunization with melanoma-cell vaccine with different adjuvants in mice. Int. J. Cancer 75, 117-124 (1998).
30. Putterman, C. & Diamond, B. Immunization with a peptide surrogate for doublestranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J. Exp. Med. 188, 29-38(1998).
31. Frassanito, M.A. et al. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CDB+ cytotoxic T lymphocyte. Cancer Res. 55, 124-128 (1995).
32. Abdel, M.U. et al. Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells. Eur. J. Immunol. 26, 544-551 (1996).
33. Bohm, C.M. et al. Carbohydrate recognition on MUC1-expressing targets enhances cytotoxicity of a T cell subpopulation. Scand. J. Immunol. 46, 27-34 (1997).
34. Dabelsteen, E. Cell surface carbohydrates as prognostic markers in human carcinomas. [Review] [141 refs]. J. Pathol. 179, 358-369 (1996).
35. Ravindranath, M.H. et al. Endothelial-selectin ligands sialyl Lewis(x) and sialyl Lewis(a) are differentiation antigens immunogenic in human melanoma. Cancer 79, 1686-1697 (1997).
36. Zhang, S. et al. Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens. Int. J. Cancer 73, 50-56 (1997).
37. Livingston, P.O. Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines. [Review]. Immunol. Rev. 145, 147-166 (1995).
38. Kitamura, K. et al. Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants. Proc. Natl. Acad. Sci. USA 91, 12957-12961 (1994).
39. Adluri, S. et al. Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients. Cancer Immunol. Immunother. 41, 185-192 (1995).
40. Phalipon, A. et al. Induction of anti-carbohydrate antibodies by phage libraryselected peptide mimics. Eur. J. Immunol. 27, 2620-2625 (1997).
41. Harris, S.L. et al. Exploring the basis of peptide-carbohydrate crossreactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies. Proc. Natl. Acad. Sci. USA 94, 2454-2459 (1997).
42. Pincus, S.H., Smith, M.J., Jennings, H.J., Burritt, J.B. & Glee, P.M. Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen. J. Immunol. 160, 293-298 (1998).
43. Valadon, P., Nussbaum, G., Boyd, L.F., Margulies, D.H. & Scharff, M.D. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. J. Mol. Biol. 261, 11-22 (1996).
44. Zhang, H., Zhong, Z. & Pirofski, L.A. Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody. Infect. Immun. 65, 1158-1164 (1997).
45. Ishikawa, D. et al. GD1α-replica peptides functionally mimic GD1α, an adhesion molecule of metastatic tumor cells, and suppress the tumor metastasis. FEBS Lett. 441, 20-24(1998).
46. Kundu, N., Beaty, T.L., Jackson, M.J. & Fulton, A.M. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer. J. Natl. Cancer Inst. 88, 536-541 (1996).